Advertisement

Topics

Pharm-Olam International Company Profile

13:32 EDT 21st September 2018 | BioPortfolio

Pharm-Olam International started operations in 1994 with the premise of delivering cost-effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries across five continents, including North America, Western Europe, Central & Eastern Europe, Latin America, Asia, and Africa. Today, POI has one of the largest global footprints of any CRO. We are committed to establishing and maintaining the industry's strongest multi-national presence. Our monitors have the most extensive knowledge of local and regional across a broad range of therapeutic areas. You can be absolutely confident that your trials are in reliable hands.
POI has an entirely different model than other CROs— We call it global decentralization. The success of this model has been proven time and again.
Your study deserves the superior management experience and clinical trial expertise of Pharm-Olam International. We are focused and committed to improving life by providing excellence in clinical research.

Location

450 N. Sam Houston Parkway, Suite 250
Houston
Texas
77060
United States of America

Contact

Phone: 1 (713) 463-8075
Fax: 1 (713) 463-8281
Email: info@pharm-olam.com


News Articles [370 Associated News Articles listed on BioPortfolio]

Pharm-Olam International Supports Clinical Trials and Sponsors Compliance with GDPR

Pharm-Olam International, a global, full-service contract research organization (CRO) specializing in oncology, infectious diseases and vaccines, rare and orphan diseases,...

YiChang HEC Pharm Raises $400 Million from Blackstone Group

YiChang HEC ChangJiang Pharm raised $400 million from Blackstone Group in the a convertible bond offering. The bonds will pay 3%. HEC Pharm, based in Yichang in central China’s Hubei province, w...

Ark Pharm’s Shady Side

Once in a while we have discussions of chemical suppliers around here – but we haven’t had one like this. On Friday afternoon, word came out that Ark Pharm, a reasonably well-known firm ou...

R-Pharm continues to dominate in segment of public procurements in Russia

R-Pharm, one of Russia’s leading drugmakers, has won the 1 billion roubles (~$16 million) tender for…

R-Pharm and AbbVie to start supplying new hepatitis C drug for state needs in Russia

R-Pharm, one of Russia’s leading drugmakers, has won a tender in Russia for the supply of Viekira Pak…

Israel's Super-Pharm chain begins selling medical cannabis

Medical cannabis supplier BOL's products at Super-Pharm will be priced at NIS 120-140 per 10 grams.

Mushrooming of diploma colleges in Punjab results in unemployment and poor standard of education

More than 80 per cent of the 5,000 pharmacy diploma holders (D Pharm) and 60 per cent of the 3,000 pharmacy graduates (B Pharm) passing out of the 160 institutions across Punjab every year remain unem...

Future Pharm Launches New Affiliate Program

New affiliate program allows Future Pharm partners, resellers and vendors to help expand the reach of Future Pharm products throughout the U.S. PHOENIX (PRWEB) June 14, 2018 Future Pharm recently ann...

PubMed Articles [485 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers" Eur. J. Pharm. Biopharm. 127 (2018) 432-442.

Complications of Botox and their Management.

Adherence to anticholinergic medications is known to be a problem in patients with overactive bladder, with only 13.2% of patients continuing anticholinergic therapy beyond 1 year D'Souza et al. (J M...

18th International Congress on Infectious Diseases/XVIII Congreso SADI 2018 - It takes two to Tango.

Respiratory Management of Extremely Preterm Infants: An International Survey.

There are significant international variations in chronic lung disease rates among very preterm infants yet there is little data on international variations in respiratory strategies.

Cohort Profile: The International Mobility In Aging Study (IMIAS).

Clinical Trials [1023 Associated Clinical Trials listed on BioPortfolio]

Vitamin D Supplementation and and Glycemic Indexes

Age affect insulin sensitivity and the metabolism, and vitamin D status was shown to have a correlation with markers of insulin resistance. That's why, we aimed in our trial to study the e...

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will con...

Personalized Health Assessment Related to Medications (Project PHARM)

This research will adapt an evidence based intervention for alcohol and other drugs and evaluate its efficacy on Prescription Stimulant Medication (PSM) misuse in web-based and in-person f...

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

Companies [1334 Associated Companies listed on BioPortfolio]

Pharm-Olam International Ltd.

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology...

Pharm-Olam International LLC

Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical...

Pharm-Olam International

Pharm-Olam International started operations in 1994 with the premise of delivering cost-effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, ...

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...

More Information about "Pharm-Olam International" on BioPortfolio

We have published hundreds of Pharm-Olam International news stories on BioPortfolio along with dozens of Pharm-Olam International Clinical Trials and PubMed Articles about Pharm-Olam International for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharm-Olam International Companies in our database. You can also find out about relevant Pharm-Olam International Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record